Reglagene, Inc.
Biotechnology company · Tucson, Arizona, United States
Reglagene, Inc. is a biotechnology company headquartered in Tucson, Arizona, United States. Its earliest recorded incorporation is in 2024. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $701,714 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $766,655 sold in a notice filed in 2024.
Reglagene at a glance
What does Reglagene do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $701,714 in total (2018 to 2019). NIH funding came from the National Cancer Institute, National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $766,655 sold (2024).
Frequently asked questions about Reglagene
Where is Reglagene headquartered?
Reglagene, Inc. is headquartered in Tucson, Arizona, United States.
What does Reglagene do?
Reglagene, Inc. is a biotechnology company.
When was Reglagene founded?
The earliest incorporation on record for Reglagene, Inc. is in 2024, according to public company registers.
Similar companies
- Precision Epigenomics IncTucson, Arizona, United States
- Microvascular Therapeutics LLCTucson, Arizona, United States
- Neutherapeutics, LLCTucson, Arizona, United States
- bioVidria, Inc.Tucson, Arizona, United States
- Luceome Biotechnologies, L.L.C.Tucson, Arizona, United States
- Proneurogen, IncTucson, Arizona, United States
- Calimmune, Inc.Tucson, Arizona, United States
- RegulonixTucson, Arizona, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences